Ybrain’s electroceutical for depression, MINDD STIM, surpasses 6,000 prescriptions

19.10.2022

Ybrain Inc.

Ybrain’s electroceutical for depression, MINDD STIM, surpasses 6,000 prescriptions

Ybrain, a company specializing in mental health diagnostics and therapeutics, said on Wednesday prescriptions for MINDD STIM, a prescription depression electroceutical for at-home use, exceeded 6,000.

MINDD STIMM is a wireless headband wearable device that delivers non-invasive brain stimulation through transcranial direct current stimulation, tDCS, to treat depression through normalization of the frontal lobe. Through this telemedicine platform, results are derived for the entire process from mobile using scale examination to hospital/home treatment and patients can directly record and manage their symptoms.

http://www.koreabiomed.com/news/articleView.html?idxno=14834

Exhibitor Data Sheet